Medical Devices & Tech

Cambridge Heart

100 Ames Pond Dr Suite 100
Tewksbury, MA 01876 USA
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Measures subtle heartbeat fluctuations to identify patients at risk for sudden cardiac arrest

Management Ali Haghighi-Mood, PhD, Chief Executive Officer; Vincenzo LiCausi, Vice President, Finance and Administration and Chief Financial Officer

Click here for Financial Data
Keywords: Cardiovascular, Cardiology, cardiac, heart, heart disease, heart diagnostics, diagnostics, noninvasive, non-invasive, stress tests

Comment


Updated: Nov. 11, 2014


Description

Cambridge Heart is a specialty medical devices company that develops and markets products for the non-invasive diagnosis of cardiac disease, with a specific focus in the area of sudden cardiac arres......view more

Products / Services

The Heartwave II system is the next generation MTWA testing platform. The test is non-invasive and takes less than 30 minutes. ECG measurements are taken during rest, exercise and then rest again in o......view more

Technology / Differentiation

The Microvolt T-Wave Alternans Test measures subtle heartbeat fluctuations which can be used to identify patients at risk for sudden cardiac arrest. In patients with negative (normal) MTWA test result...view more

Market / Customers

Sudden cardiac arrest accounts for approximately one third of all cardiac deaths, or over 400,000 deaths, in the United States each year. Cambridge sees a potentially large market opportunity, estimat......view more


Competitors / Substitutes / Alternatives

Boston Scientific Corp., Cardiodynamics International Corp., EP Medsystems...view more

Strategy

The test is now covered by the CMS, Aetna, Cigna and Humana and the company will continue to seek expand the list of participating insurance providers....view more

Status

Medicare, Cigna, Aetna and other major insurance companies cover MTWA diagnostic testing (using the spectral analytic method) for the evaluation of patients at risk of sudden cardiac arrest who are ca...view more

Analyst Coverage